On World Obesity Day, FISPGHAN reaffirms its commitment to tackling childhood obesity as a critical public health challenge affecting millions worldwide. Obesity is not just an individual concern but a global crisis requiring urgent prevention strategies. The Growing Burden of Childhood Obesity Over 37 million children under five are overweight and obese, and 160 million
read more
Baxter International’s North Carolina manufacturing facility is currently closed following damage caused by Hurricane Helene. The North Carolina site is the largest U.S. manufacturer of intravenous (IV) solutions, including saline, dextrose, and sterile water. NASPGHAN is monitoring the situation and has been participating in regular updates from federal administration officials. Products manufactured at the Baxter
read more
NASPGHAN CHILD NUTRITION AND HEALTH EQUITY WHITE HOUSE CHALLENGE AWARD Submission Deadline: October 1, 2024 Submit Now DESCRIPTION AND OBJECTIVE The NASPGHAN Child Nutrition and Health Equity White House Challenge Award is part of NASPGHAN’s commitment to the White House Challenge to End Hunger and Build Healthy Communities. This 18-month award will support innovative, bold
read more
In honor of Jewish American Heritage Month, NASPGHAN would like to pay tribute to the remarkable life and legacy of Dr. Emanuel Lebenthal, a pioneering figure in pediatric gastroenterology whose clinical and investigative work has touched the lives of countless children worldwide. As memorialized on the NASPGHAN Timeline, Dr. Lebenthal was the founding editor of
read more
Join the co-chairs of the NASPGHAN Grants Subcommittee of the Research Committee on April 10 at 8PM ET for an informative webinar on “how to apply” to the wide variety of NASPGHAN Foundation grants available for all career levels and a variety of topic interests. Get answers to the most frequently asked questions and learn
read more
Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children Thursday, March 28, 2024 2:45 – 3:30 PM EST Register The Centers for Disease Control and Prevention, in partnership with the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), and the North American Society for Pediatric Gastroenterology, Hepatology and
read more
* BREAKING NEWS * White House Accepts NASPGHAN’s Bold Commitment to End Hunger and Build Healthy Communities February 27, 2024 – Today the Biden-Harris Administration announced new commitments to the White House Challenge to End Hunger and Build Healthy Communities. NASPGHAN is excited to announce the White House has accepted its commitment of $25,000 to
read more
NASPGHAN is excited to announce the DEEP Program – Developing Educators and Expert Presenters, a first step toward creating a NASPGHAN Speakers Bureau. This exciting new course is designed to develop a cohort of expert educators who will have the opportunity to improve their presentation skills and feel more confident in their ability to be
read more
Please see the following alert from the EGID Special Interest Group. Situation: Brand name Flovent HFA will no longer be manufactured after December 31, 2023. Background: • Flovent HFA is a commonly utilized swallowed topical steroid treatment for patients with eosinophilic esophagitis (EoE). It works by the patient swallowing the aerosolized medication dispensed by a
read more
Watch our new video on the Treatment of EoE This video presents information about the current treatment options for Eosinophilic esophagitis (EoE). It does NOT address other types of food allergies or eosinophilic conditions beyond the esophagus. Always consult with your health care providers when making decisions about treatment. Supported by an educational grant from
read more